Monday's top analyst upgrades, downgrades and initiations included Apple, Bed Bath & Beyond, Chico's FAS, Clorox, Deere, Gap, Newell Brands, RealReal, Teva Pharmaceutical, UnitedHealth and Wells Fargo.
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target, Tilray and Walmart.
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S. Steel.
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apache, Caesars Entertainment, Dell Technologies, Devon Energy, Hewlett Packard Enterprise, NetApp, Nordstrom, MetLife and Snap.
Thursday was a down day for the broad U.S. markets, with each of the major indices notching a loss in the session. The Nasdaq took the worst of it seeing one of…
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
The top analyst upgrades, downgrades and other research calls from Wednesday include AutoZone, Chipotle Mexican Grill, Diamondback Energy, Hasbro, Papa John’s and Western Digital.
These are five stocks that the top hedge funds are buying, none of which is an overbought and crowded tech stock. They all make good sense for growth accounts with some risk…
The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford, Kinder Morgan, Pandora Media, Procter & Gamble and Shopify.
Tuesday was a positive day for the broad U.S. markets with each of the major exchanges recovering, if only slightly, from Monday. Crude oil was pushed much higher in the session, retreating…
Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their rheumatoid arthritis treatment.
Thursday was another positive day for the broad U.S. markets. Although markets were solid throughout the day, there was a small dip at the end from some selling pressure. At the same…
Chris Lange Acadia Pharmaceuticals, Veo, Sibanye Gold, and Incyte Pharmaceuticals all posted new 52-week lows Monday.
The top analyst upgrades, downgrades and other research calls from Monday include Alcoa, CEMEX, Comerica, Facebook, General Motors, Incyte, Proofpoint and Regeneron Pharmaceuticals.
